文献速递胸部肿瘤放疗放疗物理与技术

多形核MDSC通过抑制CD8+T细胞促进放疗后肿瘤再生长

Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8+ T Cells.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-11-22

该研究利用Lewis肺癌同系小鼠模型,发现放疗后肿瘤微环境中多形核髓源性抑制细胞(PMN-MDSC)增多,通过上调精氨酸酶1(ARG1)抑制CD8+T细胞反应,从而促进放疗后肿瘤再生长。选择性清除PMN-MDSC或抑制ARG1可延缓再生长,西地那非可减少PMN-MDSC积累及ARG1表达,提示靶向MDSC与放疗联合的潜在价值。

要点

  • 放疗后PMN-MDSC浸润增加,通过ARG1抑制CD8+T细胞功能。
  • 清除PMN-MDSC或抑制ARG1可延缓放疗后肿瘤再生长。
  • 西地那非减少放疗后PMN-MDSC积累和ARG1表达,增强抗肿瘤免疫。

核心结论

  • PMN-MDSC通过ARG1激活参与放疗诱导的免疫抑制,促进肿瘤再生长。
  • 西地那非具有增强抗肿瘤免疫的潜力,可能延缓放疗后肿瘤复发。

研究设计与样本

  • 采用Lewis肺癌同系小鼠模型,评估放疗后肿瘤浸润MDSC丰度和肿瘤生长。
  • 通过流式细胞术检测CD8+T细胞比例和功能状态,并行PMN-MDSC清除实验。
  • 检测MDSC的ARG1表达和活性,并在放疗后给予ARG1抑制剂和磷酸二酯酶5抑制剂西地那非。

主要发现

  • 放疗招募MDSC(尤其PMN亚群)进入肿瘤微环境。
  • PMN-MDSC通过升高ARG1表达抑制CD8+T细胞反应。
  • 选择性清除PMN-MDSC或抑制ARG1可促进瘤内CD8+T细胞浸润和活化,延缓放疗后再生长。
  • 西地那非减少放疗后PMN-MDSC积累和ARG1表达,减弱MDSC介导的免疫抑制。

临床怎么用

  • 放疗后靶向PMN-MDSC或其ARG1通路可能延缓肿瘤再生长。
  • 西地那非或可作为放疗辅助手段,需进一步临床验证。

局限性

  • 研究仅基于Lewis肺癌小鼠模型,结论外推需谨慎。
  • 原文未报告临床样本验证或长期安全性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation therapy (RT) is widely used in the treatment of cancer. Unfortunately, RT alone is insufficient to control the disease in most cases, as regrowth after irradiation still occur. Thus, it would be meaningful to explore the underlying mechanism of tumor regrowth after irradiation. Myeloid-derived suppressor cells (MDSCs) contribute to the immunosuppressive tumor microenvironment and hinder the therapeutic efficacy of RT. However, it is unclear whether MDSCs-mediated immune suppression contributes to local relapse after irradiation. In this article, we tried to figure out how MDSCs sabotage the therapeutic effect of RT, and tried to determine the potential synergistic effect of combination between targeting MDSCs and RT. METHODS AND MATERIALS: A syngeneic murine model of Lewis lung cancer was used. The abundance of tumor infiltrating MDSCs and tumor growth after irradiation was assessed. The percentage and functional state of CD8+ T cells were measured by flow cytometry, with or without polymorphonuclear (PMN)-MDSCs depletion. Arginase 1 (ARG1) expression and activity of MDSCs were examined by hematoxylin and eosin staining and flow cytometry. ARG1 inhibitor and phosphodiesterase 5 inhibitor sildenafil were administered after RT to figure out the underlying mechanism of MDSCs-mediated immunosuppression. RESULTS: We demonstrated that irradiation recruited MDSCs, especially the polymorphonuclear subset, into the tumor microenvironment. PMN-MDSCs inhibited the CD8+ T cell response by elevating ARG1 expression. Selective depletion of PMN-MDSCs or inhibition on ARG1 promoted the infiltration and activation of intratumoral CD8+ T cells, and delayed tumor regrowth after irradiation. We showed that sildenafil reduced the accumulation and ARG1 expression of PMN-MDSCs after irradiation, thus abrogating the MDSCs-mediated immunosuppression. CONCLUSIONS: Our results have suggested that PMN-MDSCs participate in the irradiation-induced immune suppression through ARG1 activation. We have also found that sildenafil has the potential to facilitate antitumor immunity, which provides a new alternative to delay tumor recurrence after RT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Zhang Md J, Zhang Md L, Yang Md Y, et al. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8+ T Cells. Int J Radiat Oncol Biol Phys. 2020. PMID: 33238192. doi:10.1016/j.ijrobp.2020.11.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。